跳至主要内容
临床试验/NCT03590925
NCT03590925Unknown不适用

Evaluation of the Improvement of Primary Prevention in Ischemic Cardiomyopathy Patients Using New Screening and Referring System (Advance-ICM)

Yonsei University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2018年3月21日最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
试验地点
1
主要终点
Improvement of the quality of care in patients with ICM

研究概览

简要总结

The patients who undergo ICD(implantable cardioverter defibrillator) implantation for the primary prevention of sudden cardiac death with severe LV(left ventricle) dysfunction (ejection fraction ≤ 40%) by ICM(idiopathic cardiomyopathy).

Indications for ICD implantation for primary prevention in accordance with 2016 revised Korean indication guideline on ICD implantation

  • FU LVEF(Left Ventricular Ejection Fraction) ≤ 30% (at least 40 days post-myocardial infarction)
  • FU LVEF 31~35%, NYHA(the New York Heart Association) class II, III (at least 40 days post-myocardial infarction)
  • FU LVEF ≤ 40%, NSVT(non-sustained ventricular tachycardia) (Holter), inducible VF(ventricular flutter) or sustained VT(ventricular tachycardia) at electrophysiological study (at least 40 days post-myocardial infarction)

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80 years
  • Patients eligible for the indications for ICD implantation for primary prevention indication in accordance with 2016 revised Korean indication guideline on ICD implantation
  • Patients should be managed by non-EP physician
  • Patients who are willing to sign the informed consent
  • Patients who are willing to receive the implantation and post-operative follow-up

排除标准

  • Malignant tumor
  • Life expectancy < 12 months
  • Patients unable or unwilling to cooperate in the study procedures

结局指标

主要结局

Improvement of the quality of care in patients with ICM

时间窗: 3 years

the rate of device therapy(ICD or CRT-D(Cardiac Resynchronization Therapy-Device))

次要结局

  • Improvement of the cardiovascular outcome of patients(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of the Improvement of Primary Prevention... | 临床试验